A rounding error they can ill afford to lose when their stock is down nearly 30% from a year ago. Idexx kicking Abaxis’ ass here, a competitor to Simparica Trio there. It all adds up.
Don't get too excited its a small piece of the pie, and they’ve been jacking up the price on it for years…. don’t forget they are ramping up their Amazon and over-the-counter retail teams to sell more outside of the veterinary hospitals. A competitive product to Apoquel would have a big impact...
